跳至主要内容
临床试验/NCT07045987
NCT07045987Enrolling By Invitation不适用

FUtile Reperfusion in acuTe iscHEmic stRoke- FURTHER

Xijing Hospital1 个研究点 分布在 1 个国家目标入组 2,000 人开始时间: 2025年6月1日最近更新:

试验速览

阶段
不适用
状态
Enrolling By Invitation
发起方
入组人数
2,000
试验地点
1
主要终点
3-month mRS score

研究概览

简要总结

The goal of this prospective cohort registration study is to establish an early warning system for futile recanalization in acute ischemic stroke by analyzing multi-omics information to identify key regulatory nodes and target molecules in ineffective recanalization.

The core issue addressed by this research is: Identifying key regulatory nodes and target molecules closely associated with futile recanalization, revealing the interactions among the neurovascular unit, peripheral immune cells, and the brain lymphatic system, as well as developing early diagnostic biomarkers and novel diagnostic technologies for futile recanalization.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Aged ≥18 years
  • Acute ischemic stroke confirmed by clinical and neuroimaging criteria (CT or MRI)
  • Clinical indication for thrombectomy
  • Provision of signed informed consent

排除标准

  • Preexisting dementia or severe disability (modified Rankin Scale score ≥3)
  • Cerebral vascular malformations, neoplasms, abscesses, or other significant non-ischemic brain pathologies
  • Life-limiting systemic comorbidities (e.g., end-stage organ failure, metastatic malignancies) with anticipated survival <6 months
  • Patient or legally authorized representative declined consent
  • Anticipated poor protocol adherence or loss to follow-up

结局指标

主要结局

3-month mRS score

时间窗: From enrollment to the end of treatment at 3 months

次要结局

未报告次要终点

研究者

发起方
Xijing Hospital
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验